期刊
CANCER LETTERS
卷 498, 期 -, 页码 130-141出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.10.044
关键词
Cervical cancer; LINC00657; miR-20a-5p; RUNX3; DR5
类别
资金
- National Natural Science Foundation of China [81972449]
- Hubei Provincial Natural Science Foundation of China [2019CFA016]
The study reveals that LINC00657 suppresses cervical cancer progression by inducing NK cell tolerance through regulating the miR-20a-5p/RUNX3/DR5 axis. LINC00657 acts as a tumor-suppressor by inhibiting cervical cancer cell growth and invasion.
Long noncoding RNAs act essential regulators in cervical cancer progression. Our study aimed to investigate the underlying function and molecular mechanisms of LINC00657 in cervical cancer. QRT-PCR results indicated that LINC00657 was significantly decreased in cervical cancer. Gain-and loss-of-function experiments were performed in SiHa and HeLa. Functional assays demonstrated that LINC00657 inhibited cervical cancer cell growth, migration and invasion. Moreover, miR-20a-5p was confirmed as a target of LINC00657. Furthermore, miR-20a-5p promoted the development of cervical cancer via targeting RUNX3. DR5 acts as a vital promoter in activating NK cells and is a downstream target of RUNX3. We found that LINC00657 overexpression promoted the cytotoxic activity of NK cells via regulating RUNX3/DR5 axis. Therefore, LINC00657 suppressed cervical cancer progression via inducing miR-20a-5p/RUNX3/DR5 mediated NK cell tolerance. In conclusion, LINC00657 was identified as a novel tumor-suppressor in cervical cancer and could function as a potential therapeutic target for clinical treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据